Scinai Immunotherapeutics Ltd ADR (SCNI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,450 | 170 | 30 | 1 | 3 |
| Receivables | 1,510 | 0 | 160 | 0 | 0 |
| Inventories | 1,850 | 910 | 820 | 0 | 0 |
| Other current assets | 60 | 1,020 | 270 | 0 | 0 |
| TOTAL | $4,870 | $2,100 | $1,280 | $1 | $3 |
| Non-Current Assets | |||||
| PPE Net | 40 | 40 | 50 | 0 | 0 |
| Other Non-Current Assets | 230 | 290 | 350 | 0 | 0 |
| TOTAL | $270 | $330 | $400 | $0 | $0 |
| Total Assets | $5,150 | $2,440 | $1,700 | $1 | $3 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 400 | 800 | 640 | 1 | 20 |
| Accrued Expenses | 140 | 150 | 120 | 1 | 0 |
| Other current liabilities | 0 | 20 | 0 | 0 | 0 |
| TOTAL | $1,040 | $1,790 | $1,610 | $2 | $20 |
| Non-Current Liabilities | |||||
| Long Term Debt | 0 | 0 | 0 | 3 | 4 |
| TOTAL | $0 | $0 | $0 | $3 | $4 |
| Total Liabilities | $1,040 | $1,790 | $1,610 | $5 | $20 |
| Shareholders' Equity | |||||
| Common Shares | 5,780 | 4,120 | 3,060 | 2,530 | 1,690 |
| Retained earnings | -2,380 | -3,440 | -2,970 | -4,770 | -3,370 |
| Other shareholders' equity | 700 | -40 | 0 | 6 | 10 |
| TOTAL | $4,100 | $640 | $90 | $-4 | $-20 |
| Total Liabilities And Equity | $5,140 | $2,430 | $1,700 | $1 | $0 |